Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.
Gregory Reaman Elected Chairman, C.O.G.; NCI Seeks Nominations For Consumer Group. “We Need A Long-Term Commitment” To Discovery.
First NCI Director To Resign Due To Presidential Election?
EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.
Perot Systems To Provide IT Support For US Oncology Enterprise Applications.
Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.
Firm Wins Patent For Method, Apparatus For Cryoablation.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research
